Cytel Market Access, HEOR & RWE
At Cytel, we provide the deep insights and expertise necessary for making confident development decisions. Our global team helps generate evidence that complements traditional randomized clinical trials, accelerates submissions, expands indications, and supports health-economic decision-making.
We are excited to see you at ISPOR Europe 2023 on the 12th - 15th November where, once again, Cytel is honored to have the greatest number of Issue Panels & Workshop presentations, a testament to our commitment as a scientific and methodological leader. This year, visit us at Booth #C3-049 to connect with our HEOR & RWE experts on topics such as RWE and Health Disparities in HTAs, Quantitative Bias Analysis, RWE Sources in HTA Submissions and more.
Fill out the form to pre-book a meeting with the Cytel team to learn more about our innovative offerings in Market Access, HEOR & RWE.
Meet with us at ISPOR Europe
HEOR & RWE Focused Blogs
Sorry no results please clear the filters and try again
Mind the Health Gap: Is It Time to Reliably Measure the Impact of Health Inequity in Product Development and Assessment? Yes, It Is.
Looking to the Future — Improving Diagnosis and Prognosis of Eye Conditions with Artificial Intelligence
Real World & Advanced Analytics
Through our advanced analytics, Cytel provides the richer, deeper insights necessary for making confident development decisions. We generate evidence which complements traditional randomized clinical trials, accelerates submissions, expands indications, and supports health-economic decision-making.
Click to learn more about our HEOR, RWE, LiveSLR, and more offerings.